Molina Healthcare (NYSE:MOH – Get Free Report) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday.
Other research analysts have also issued reports about the stock. JPMorgan Chase & Co. restated a “neutral” rating and issued a $350.00 price objective (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Truist Financial decreased their price target on shares of Molina Healthcare from $400.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Stephens reaffirmed an “equal weight” rating and set a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday. UBS Group decreased their target price on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a research report on Friday. Finally, Robert W. Baird dropped their price target on Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $355.67.
Get Our Latest Analysis on Molina Healthcare
Molina Healthcare Stock Down 0.4 %
Molina Healthcare (NYSE:MOH – Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.92% and a return on equity of 27.88%. Sell-side analysts anticipate that Molina Healthcare will post 23.44 EPS for the current year.
Hedge Funds Weigh In On Molina Healthcare
Several institutional investors and hedge funds have recently modified their holdings of the stock. State Street Corp boosted its stake in Molina Healthcare by 0.5% in the 3rd quarter. State Street Corp now owns 2,614,311 shares of the company’s stock worth $900,787,000 after purchasing an additional 13,001 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Molina Healthcare by 2.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company’s stock worth $116,443,000 after buying an additional 10,002 shares in the last quarter. Los Angeles Capital Management LLC grew its holdings in shares of Molina Healthcare by 166.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company’s stock valued at $57,195,000 after buying an additional 122,674 shares during the last quarter. Swiss National Bank grew its holdings in shares of Molina Healthcare by 0.3% during the third quarter. Swiss National Bank now owns 173,900 shares of the company’s stock valued at $59,919,000 after buying an additional 500 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its position in shares of Molina Healthcare by 2.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 149,573 shares of the company’s stock valued at $43,533,000 after acquiring an additional 3,238 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.
About Molina Healthcare
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
- Five stocks we like better than Molina Healthcare
- How to Invest in Biotech Stocks
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Basic Materials Stocks Investing
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.